Eric Auger, Partner, was an expert panelist at the April 4, 2019 Guggenheim Healthcare Talks Rare Disease and Genomic Medicines Day in Cambridge, Massachusetts. The session was titled “Gene Therapy Pricing: Challenges to Innovative Payment Models and Potential Solutions”. Based upon his work with pioneering gene- and cell-therapy companies, Eric was invited to discuss the market access and payment model issues that gene-therapy companies face, experiences of pioneering products and companies, and considerations for pricing and payment model innovation as the sector grows. In addition to Eric, Joshua Cohen, formerly at Tufts Center for the Study of Drug Development participated on the panel.
The session was hosted by Whitney Ijem and Michael Schmidt of Guggenheim Partners.